I think what you posted over at Ibash is pretty spot on. At this point, the longs have said there piece, are accumulating when we can and waiting for advancement in "our" companies position in relation to FDA approval of Hemaxellerate and IND submission of the Min Gene Silencing product. Now, as we wait, and watch this slow day to day churn, we can surmise by past similar stock trends where we might end up or some of us will share some DD about the industry we are invested in.

I'm kind of thinking (maybe hoping is a better word) that we may get a bonus along the way and Koos might be working on a third addition to the portfolio.

Either way, patience will prevail in my opinion and soon these days of watching the churn will be a distant memory.